Detrimental deletions: Mitochondria, aging and Parkinson's disease

BioEssays

Volumn 28, Issue 10, 2006, Pages 963-967

  Biskup, Saskia ^a   Moore, Darren J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

AGING; BRAIN MITOCHONDRION; CELL LOSS; DOPAMINERGIC NERVE CELL; GENE DELETION; HUMAN; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; REVIEW; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; AGING; DNA, MITOCHONDRIAL; DOPAMINE; HUMANS; MITOCHONDRIA; PARKINSON DISEASE; SEQUENCE DELETION; SUBSTANTIA NIGRA;

PARKINSONIA;

EID: 33750018371     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20471     Document Type: Review

References (53)

1. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, et al. 2006. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38:515-517.
2. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, et al. 2006. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38:518-520.
3. Chan DC. 2006. Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241-1252.
4. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, et al. 2003. Mitochondrial threshold effects. Biochem J 370:751-762.
5. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beat MF, et al. 1992. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2:324-329.
6. Soong NW, Hinton DR, Cortopassi G, Arnheim N. 1992. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 2:318-323.
7. Itoh K, Weis S, Mehraein P, Muller-Hocker J. 1997. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study. Mov Disord 12:9-16.
8. He L, Chinnery PF, Durham SE, Blakely EL, Wardell TM. 2002. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 30:e68.
9. Beal MF. 2005. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495-505.
10. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, et al. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:417-423.
11. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, et al. 2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:481-484.
12. Ruan H, Tang XD, Chen ML, Joiner ML, Sun G, et al. 2002. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 99:2748-2753.
13. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, et al. 2005. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308:1909-1911.
14. Lu T, Pan Y, Kao SY, Li C, Kohane I, et al. 2004. Gene regulation and DNA damage in the ageing human brain. Nature 429(6994):883-891.
15. Langsten JW, Ballard P, Tetrud JW, Irwin I. 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
16. Dauer W, Przedborski S. 2003. Parkinson's disease: mechanisms and models. Neuron 39:889-909.
17. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. 2002. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277:1641-1644.
18. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, et al. 2002. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119-127.
19. Sherer TB, Kim JH, Betarbet R, Greenamyre JT. 2003. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179:9-16.
20. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.
21. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, et al. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54:823-827.
22. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, et al. 1996. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40:663-671.
23. Swerdlow RH, Parks JK, Cassarino DS, Binder DR, Bennett JP, Jr, et al. 2001. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Exp Neurol 169:479-485.
24. Woolen GF, Currie LJ, Bennett JP, Harrison MB, Trugman JM, et al. 1997. Maternal inheritance in Parkinson's disease. Ann Neurol 41:265-268.
25. Swerdlow RH, Parks JK, Davis JN, 2nd, Cassarino DS, Trimmer PA, et al. 1998. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann Neurol 44:873-881.
26. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, et al. 2003. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72:804-811.
27. Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, et al. 2005. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 57:564-567.
28. Moore DJ, West AB, Dawson VL, Dawson TM. 2005. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57-87.
29. Abou-Sleiman PM, Muqit MM, Wood NW. 2006. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 7:207-219.
30. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, et al. 2004. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279:18614-18622.
31. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, et al. 2003. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100:4078-4083.
32. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, et al. 2004. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131:2183-2194.
33. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, et al. 2003. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria- dependent cell death. Hum Mol Genet 12:517-526.
34. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. 2004. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101:9103-9108.
35. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, et al. 2005. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102:5215-5220.
36. Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, et al. 2005. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol 15:1572-1577.
37. Moore DJ, Dawson VL, Dawson TM. 2006. Lessons from Drosophila models of DJ-1 deficiency. Sci Aging Knowledge Environ 2006(2):pe2.
38. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, et al. 2005. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14:2063-2073.
39. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al. 2006. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162-1166.
40. Park J, Lee SB, Lee S, Kim Y, Song S, et al. 2006. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157-1161.
41. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. 2004. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160.
42. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, et al. 2006. PINK1 protein in normal human brain and Parkinson's disease. Brain 129:1720-1731.
43. Hirsch E, Graybiel AM, Agid YA. 1988. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-348.
44. Damier P, Hirsch EC, Agid Y, Graybiel AM. 1999. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122:1437-1448.
45. Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, et al. 2002. Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99:14524-14529.
46. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, et al. 2005. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413-3418.
47. Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, et al. 2006. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis 21:541-548.
48. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, et al. 2006. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26:41-50.
49. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, et al. 2006. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 103:10793-10798.
50. West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, et al. 2005. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102:16842-16847.
51. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, et al. 2001. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8:613-621.
52. Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, et al. 2004. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 24:9848-9862.
53. Hance N, Ekstrand MI, Trifunovic A. 2005. Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis. Hum Mol Genet 14:1775-1783.